Executive Board

Dr. Gitte Neubauer (Chair)
CEO of Cellzome GmbH - a GSK company, Heidelberg
Prof. Dr. Michael Boutros (Deputy Chair)
 
Head of Functional and Structural Genomics Program at the German Cancer Research Center (DKFZ), Heidelberg
Dr. André H.R. Domin
Managing Director of the Technologiepark Heidelberg GmbH, Heidelberg
Dr. Stefan Herr
CEO of EMBL Ventures GmbH, Heidelberg
Prof. Dr. Magnus von Knebel Doeberitz
Director, Department of Applied Tumor Biology, Institute of Pathology, University of Heidelberg
Dr. Volker Stadler
CEO of PEPperPRINT GmbH, Heidelberg
Dr. Axel Wiest
Chief Operating Officer R&D, Merck KGaA, Darmstadt
Dr. André H.R. Domin
Managing Director of the Technologiepark Heidelberg GmbH, Heidelberg
Prof. Dr. Magnus von Knebel Doeberitz
Medical Director, Department of Applied Tumor Biology, Institute of Pathology, Heidelberg University Hospital
Dr. Claus Kremoser
CEO of Phenex Pharmaceuticals AG, Heidelberg
Dr. Volker Stadler
CEO of PEPperPRINT GmbH, Heidelberg

Strategic Advisory Board

The strategic board is an advisory body, endoursed with the task of advising the executive board particularly on strategic issues or reviewing executive board decisions.
Dr. Ulrich Betz, Vice President Innovation; Department Head Future Insight, Merck KGaA; Department Head Innovation & Entrepreneurship Incubator, Merck Healthcare KGaA
Dr. Siegfried Bialojan, Executive Director, Head Life Science Center, Ernst & Young GmbH, Mannheim
Dr. Elmar Bourdon, Manager of Medical Technology Cluster, City of Mannheim
Prof. Dr. Bernd Bukau, Director of Zentrum für Molekulare Biologie Heidelberg (ZMBH)
Dr. Jürgen Gamer, VP Business Development Apogenix AG, Heidelberg
Dr. Jan Gradel, Director Business Development Sino German Hi Tech Park Holding GmbH, Heidelberg
Martin Haag, Site Manager, Roche Diagnostics GmbH, Mannheim
Thomas Hegendoerfer, New Ventures Lead in Germany for Johnson & Johnson Innovation, Neuss
Dr. Andreas Kempff, Managing Director, Department of Industry, Innovation and Enterprise Promotion, Chamber of Industry and Commerce (IHK) Rhine-Neckar, Heidelberg
Dr. Martin Raditsch, CEO INNOVECTIS GmbH, Frankfurt am Main
Dr. Chistian Tidona (Chair), Managing Director BioMed X GmbH, Heidelberg
Dr. Joachim Vogt, Director Search & Evaluation Western Europe at AbbVie
Dr. Alexander Wartini, CEO, ScienceValue Heidelberg GmbH Technology Transfer for the Ruprecht-Karls
University, Heidelberg
Dr. Rainer Wessel, Director Innovation Management, German Cancer Research Center (DKFZ), Heidelberg
Prof. Dr. Heike Andrea Wieland, Director External Ecosystem R&D, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main

Scientific Advisory Board

The Scientific Advisory Board is an advisory body entrusted with the task of advising the executive board particularly in the selection and evaluation of project ideas and projects
Dr. Christoph Antz, CEO, Velabs Therapeutics GmbH, Heidelberg
Dr. Juergen Bauer, Deputy Managing Director, EMBLEM Technology Transfer GmbH, Heidelberg
Prof. Dr. Adelheid Cerwenka, Professor of Immunobiochemistry Heidelberg University, Medical Faculty Mannheim
PD Dr. Gerard Drewes, Head of Science, Cellzome GmbH – a GSK company, Heidelberg
Prof. Dr. Mathias Hafner (Chair), Vice President for Research and Technology Transfer at Mannheim University of Applied Sciences
Dr. Lena Krzyzak, Principal in Life Science Team, High-Tech Gründerfonds
Dr. Holger Hess-Stumpp, Strategic Alliance Manager Oncology, Bayer AG, Berlin
Dr. Thomas Höger, CEO and co-founder, Apogenix GmbH, Heidelberg
Prof. Dr. Carsten Hopf, Head of Institute for Instrumental Analytics and Bioanalytics Mannheim University of Applied Sciences
Dr. Friedrich Rippmann, Director, Computational Chemistry & Biology Global R&D, Discovery Technologies Merck KGaA, Darmstadt
Prof. Dr. Andreas Trumpp, Managing Director of HI-STEM, Professor and Head of the Division of Stem Cell and Cancer at the DKFZ Heidelberg
Dr. Magnus Walter, Senior Director Drug Discovery, Medicinal Chemistry and Screening Biology, AbbVie Germany